PATENT CLAIM ANALYSIS

Application Number: 16355352
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "263200"]

Abstract:
The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R 1 , R 4  and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

Claim (Index 3):
The compound of  claim 1 , wherein A is selected from: wherein:\n each R 2  is independently: H; D; \u2014C 1-4  alkyl; \u2014C 1-4  haloalkyl; C 1-4  alkoxy; \u2014CN, halo; \u2014C(O)CH 3 ; \u2014NH 2 ; NHC 1-4  alkyl wherein the C 1-4  alkyl optionally comprises an oxygen heteroatom or an \u2014OH substitutent; \u2014NHC(O)\u2014C 1-4 alkyl; \u2014NHCH 2 C(O)N(C 1-4 alkyl) 2 ; benzylamino; and \u2014NH\u2014C 4-6 heterocyclo comprising an oxygen heteroatom; \n each R 3  is independently: H; D: \u2014C 1-4  alkyl; \u2014C 1-4  haloalkyl; \u2014CN; NR 14 R 15 ; or halo; \n p is 0, 1 or 2; and \n q is 0 or 1.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.56
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14118113', '16033632', '15298686', '15459141', '15945852']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7891895312953958
- 35 USC 102 Novelty (BERT): 0.5168882287282283
- Combined Prediction Score: 0.7619594010386791
- Mean Citation Score: 320.109122
- Max Citation Score: 323.93375
- Similarity Product: 258.07562468558547

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test